×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
ETNB – 89bio, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
ETNB
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
10/31
09:52 am
etnb
89BIO (NASDAQ:ETNB) had its "overweight" rating reaffirmed by analysts at Cantor Fitzgerald.
Neutral
Report
89BIO (NASDAQ:ETNB) had its "overweight" rating reaffirmed by analysts at Cantor Fitzgerald.
10/22
06:57 am
etnb
89BIO (NASDAQ:ETNB) was downgraded by analysts at Zacks Research from a "hold" rating to a "strong sell" rating.
Neutral
Report
89BIO (NASDAQ:ETNB) was downgraded by analysts at Zacks Research from a "hold" rating to a "strong sell" rating.
10/16
04:58 pm
etnb
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: 89bio, Inc. (Nasdaq - ETNB), Barinthus Biotherapeutics plc (Nasdaq - BRNS), Verint Systems Inc. (Nasdaq - VRNT), Dayforce, Inc. (NYSE- DAY)
Low
Report
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: 89bio, Inc. (Nasdaq - ETNB), Barinthus Biotherapeutics plc (Nasdaq - BRNS), Verint Systems Inc. (Nasdaq - VRNT), Dayforce, Inc. (NYSE- DAY)
10/8
11:22 am
etnb
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: 89bio, Inc. (Nasdaq - ETNB), Barinthus Biotherapeutics plc (Nasdaq - BRNS), Verint Systems Inc. (Nasdaq - VRNT), Dayforce, Inc. (NYSE- DAY)
Low
Report
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: 89bio, Inc. (Nasdaq - ETNB), Barinthus Biotherapeutics plc (Nasdaq - BRNS), Verint Systems Inc. (Nasdaq - VRNT), Dayforce, Inc. (NYSE- DAY)
10/6
05:10 pm
etnb
89bio Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of 89bio, Inc. - ETNB
Low
Report
89bio Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of 89bio, Inc. - ETNB
10/2
02:05 am
etnb
89BIO (NASDAQ:ETNB) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
Low
Report
89BIO (NASDAQ:ETNB) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
10/1
04:51 pm
etnb
Roche commences tender offer for all shares of 89bio, Inc. for $14.50 per share in cash, plus a non-tradeable contingent value right for up to $6.00 per share in cash [Yahoo! Finance]
Low
Report
Roche commences tender offer for all shares of 89bio, Inc. for $14.50 per share in cash, plus a non-tradeable contingent value right for up to $6.00 per share in cash [Yahoo! Finance]
9/30
12:44 pm
etnb
89bio, Inc. (ETNB) Shareholders to Receive Up to $3.5B Total in Roche Buyout Deal [Yahoo! Finance]
Low
Report
89bio, Inc. (ETNB) Shareholders to Receive Up to $3.5B Total in Roche Buyout Deal [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
9/19
10:59 am
Downgrades
Strong-Buy
Market Perform
Raymond James Financial, Inc.
Low
Report
-0.4%
Date
Time
Symbol
Headline
Impact
10/31
10:42 am
etnb
Form SCHEDULE 13D/A 89bio, Inc. Filed by: Adage Capital Management, L.P.
Neutral
Report
Form SCHEDULE 13D/A 89bio, Inc. Filed by: Adage Capital Management, L.P.
10/30
08:34 pm
etnb
Form 4 89bio, Inc. For: Oct 30 Filed by: LAPORTE KATHLEEN
Neutral
Report
Form 4 89bio, Inc. For: Oct 30 Filed by: LAPORTE KATHLEEN
10/30
08:31 pm
etnb
Form 4 89bio, Inc. For: Oct 30 Filed by: Hayden Michael R
Neutral
Report
Form 4 89bio, Inc. For: Oct 30 Filed by: Hayden Michael R
10/30
08:28 pm
etnb
Form 4 89bio, Inc. For: Oct 30 Filed by: Martins Ryan
Neutral
Report
Form 4 89bio, Inc. For: Oct 30 Filed by: Martins Ryan
10/30
08:25 pm
etnb
Form 4 89bio, Inc. For: Oct 30 Filed by: Altschuler Steven
Neutral
Report
Form 4 89bio, Inc. For: Oct 30 Filed by: Altschuler Steven
10/30
08:23 pm
etnb
Form 4 89bio, Inc. For: Oct 30 Filed by: PALEKAR ROHAN
Neutral
Report
Form 4 89bio, Inc. For: Oct 30 Filed by: PALEKAR ROHAN
10/30
08:22 pm
etnb
Form 4 89bio, Inc. For: Oct 30 Filed by: McWherter Charles
Neutral
Report
Form 4 89bio, Inc. For: Oct 30 Filed by: McWherter Charles
10/30
08:20 pm
etnb
Form 4 89bio, Inc. For: Oct 30 Filed by: Atkinson Edward Morrow III
Neutral
Report
Form 4 89bio, Inc. For: Oct 30 Filed by: Atkinson Edward Morrow III
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
11/15
Form 8-K 89bio, Inc. For: Nov 13
16.7%
3/18 Q4/2019 12/31/2019 EPS 2.580 ZacksConsensus -0.810 ActVsEst 3.390 - Beat 13.1%
11/13 Form 4 89bio, Inc. For: Nov 11 Filed by: Kolchinsky Peter 12.9%
4/23 Form 8-K 89bio, Inc. For: Apr 17 10.9%
11/25 Form SC 13G 89bio, Inc. Filed by: Venrock Healthcare Capital Partners II, L.P. 9.0%
2/21 89bio to Present at the SVB Leerink 9th Annual Global Healthcare Conference 7.7%
3/26 Form 8-K 89bio, Inc. For: Mar 23 7.6%
2/14 Form SC 13G 89bio, Inc. Filed by: Nussbaum Ran 5.5%
11/8 Form S-1MEF 89bio, Inc. 4.0%
11/12 Form 424B4 89bio, Inc. 3.8%
3/18 Q4/2019 12/31/2019 EPS 2.580 ZacksConsensus -0.810 ActVsEst 3.390 - Beat 13.1%
11/13 Form 4 89bio, Inc. For: Nov 11 Filed by: Kolchinsky Peter 12.9%
4/23 Form 8-K 89bio, Inc. For: Apr 17 10.9%
11/25 Form SC 13G 89bio, Inc. Filed by: Venrock Healthcare Capital Partners II, L.P. 9.0%
2/21 89bio to Present at the SVB Leerink 9th Annual Global Healthcare Conference 7.7%
3/26 Form 8-K 89bio, Inc. For: Mar 23 7.6%
2/14 Form SC 13G 89bio, Inc. Filed by: Nussbaum Ran 5.5%
11/8 Form S-1MEF 89bio, Inc. 4.0%
11/12 Form 424B4 89bio, Inc. 3.8%
TOP News Decliners
12/18
Form 10-Q 89bio, Inc. For: Sep 30
-14.9%
4/29 89bio (NASDAQ: ETNB) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $28.00 price target on the stock. -9.5%
12/9 89bio (NASDAQ: ETNB) is now covered by analysts at Bank of America Corp. They set a "neutral" rating on the stock. -7.7%
11/12 89Bio debuts IPO [Reuters] -5.0%
12/31 Form 8-K 89bio, Inc. For: Dec 24 -4.5%
4/7 89bio (NASDAQ: ETNB) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $24.00 price target on the stock. -4.2%
4/23 89bio (NASDAQ: ETNB) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. -3.8%
2/19 Form 4 89bio, Inc. For: Feb 14 Filed by: PALEKAR ROHAN -3.7%
11/21 Form SC 13D 89bio, Inc. Filed by: Longitude Capital Partners III, LLC -2.3%
4/7 89bio (NASDAQ: ETNB) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. -2.1%
4/29 89bio (NASDAQ: ETNB) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $28.00 price target on the stock. -9.5%
12/9 89bio (NASDAQ: ETNB) is now covered by analysts at Bank of America Corp. They set a "neutral" rating on the stock. -7.7%
11/12 89Bio debuts IPO [Reuters] -5.0%
12/31 Form 8-K 89bio, Inc. For: Dec 24 -4.5%
4/7 89bio (NASDAQ: ETNB) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $24.00 price target on the stock. -4.2%
4/23 89bio (NASDAQ: ETNB) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. -3.8%
2/19 Form 4 89bio, Inc. For: Feb 14 Filed by: PALEKAR ROHAN -3.7%
11/21 Form SC 13D 89bio, Inc. Filed by: Longitude Capital Partners III, LLC -2.3%
4/7 89bio (NASDAQ: ETNB) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. -2.1%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: